12-14.06.2024 – INTRODUCTORY COURSE IN EXPLORATORY MEDICINES DEVELOPMENT
Format: In Person Training
Date: From 12 April 2024 to 14 April 2024
Venue:
Tagungshaus- und Bildungshaus
des Bistums Limburg
Wilhelm-Kempf-Haus 1
65207 Wiesbaden (Germany)
AGAH is glad to offers again, the successful continuation of the introductory course
into the principles of early clinical trials. Developed by a group of highly accomplished experts in clinical pharmacology and translational medicine with the intention to transmit a great deal of knowledge upon design, planning, coordination and inter-pretation of early phase clinical trials.
The course is intended to postgraduates in life sciences, interested in early clinical development of medicinal products. Two training parts of several days provide a concise overview on Human Pharmacology/Translational Medicine spanning from non-clinical pharmacology and toxicology over first-in-man studies to proof-of-concept clinical trials…
The course meets the standards for high-quality postgraduate education and training in Medicines Development established by PharmaTrain and has been awarded a PharmaTrain Recognition.
REGISTRATION & MORE INFORMATION
Click Here
14.06.2024 – EUFEMED Webinar: Preferences of Phase I participants

We live in rapidly changing times. Do we still know the expectations and preferences of our healthy trial participants? Do we know about their reasons for joining a trial and the information they would like to get before and after their participation? Do we know about their interest in supporting the research team from their perspective as a participant?
To better understand the situation today, EUFEMED has performed a European survey and received 4349 evaluable responses from Belgium, France, Netherlands, Germany, Hungary, United Kingdom and other countries.
In this webinar we will present the results. Please join us in discussing the findings and their impact.
Format: Webinar
Date: 14 June 2024, from 4.00 PM to 5.30 PM CEST
Agenda
16:00 – Welcome, Introduction, Moderation by Ingrid Klingmann, EUFEMED, Pharmaplex
16:05 – Content, dissemination and returns of the Survey by Dick de Vries
16:20 – Results: Reasons for participation and needs during the trial by Thijs Van Iersel, ICON + Discussion
16:55 – Results: Expectations for additional information and contribution options as well as participants’ attitude towards risks in the trial by Jelle Klein, SGS, EUFEMED + Discussion
17:30 – End of the webinar
REGISTRATION & MORE INFORMATION
Click Here
28-30.05.2021: EUFEMED Virtual Annual Conference 2021
EUFEMED is delighted to announce that our Annual Conference 2021 will be going ahead virtually in a new and exciting format.
The third EUFEMED CONFERENCE will be held on 28-30 April 2021 and is entitled
“Exploratory Development of Novel Therapeutic Approaches – Focused strategies based on lessons learned in the pandemic”.
The conference provides a unique opportunity to hear about the pandemic experience from regulators, sponsors and those working in CROs. We invite you to join us.
Find out more here:
www.eufemed-conference.eu/2021/
15.12.2023: EUFEMED Scientific Christmas lecture: The (early) clinical development of new analgesics: the point of view of a pain clinician (online)
Scientific Christmas Lecture
Webinar on 15 December 2023 at 16:00-17:30 CET
Organiser: Jan De Hoon
SAVE THE DATE!
15.09.2023: Patient/Participant engagement in exploratory clinical development (online)

Patient/Participant engagement in exploratory clinical development
Webinar on 15 September 2023 at 16:00-17:30 CET
Organiser: Ingrid Klingmann
Register Here